Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Buy
+274,143
New +$1.21M ﹤0.01% 2333
2025
Q4
Sell
-186,451
Closed -$1.27M 3797
2025
Q3
$1.27M Sell
186,451
-88,034
-32% -$727K ﹤0.01% 2099
2025
Q2
$3.74M Buy
+274,485
New +$2.59M 0.01% 1265
2025
Q1
Sell
-34,891
Closed -$173K 3369
2024
Q4
$173K Buy
+34,891
New +$183K ﹤0.01% 2866
2024
Q3
Sell
-110,762
Closed -$760K 2930
2024
Q2
$760K Buy
+110,762
New +$1.01M ﹤0.01% 1608
2022
Q2
Sell
-14,859
Closed -$52K 2329
2022
Q1
$52K Hold
14,859
﹤0.01% 1863
2021
Q4
$58K Sell
14,859
-45,141
-75% -$213K ﹤0.01% 2262
2021
Q3
$373K Buy
+60,000
New +$512K 0.01% 1869

Other funds holding LFMD

Paul Tudor Jones's LFMD Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in LifeMD (LFMD) in Q2 2026: 274,143 shares worth $1.13M. The stake represents ﹤0.01% of the portfolio and ranks #2333 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in LFMD as recently as Q3 2025.

Paul Tudor Jones first reported a position in LFMD in Q3 2021 and has held it in 8 quarters since. The position peaked at $3.74M in Q2 2025. 115 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • Paul Tudor Jones held 274,143 shares of LifeMD worth $1.13M as of Q2 2026.
  • LifeMD was a new Paul Tudor Jones position in Q2 2026.
  • LifeMD made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #2333 holding.
  • Paul Tudor Jones first reported a position in LifeMD in Q3 2021 and has held it in 8 quarters since.
  • Paul Tudor Jones's LifeMD position peaked at $3.74M in Q2 2025.
  • 115 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.